natco pharma semaglutide beats rivals with Rs 1,290 launch as Novo Nordisk patent expires Pharma News Live | Natco

Long-Term Heart Health and GLP-1s Interestingly, while some people worry about chest pain as a side effect, the long-term data on semaglutide actually points toward cardiovascular benefits

Contact your GP or healthcare provider within 24 hours if you experience: New or persistent abdominal pain in the right upper quadrant or epigastrium lasting more than a few hours Recurrent episodes of abdominal pain, particularly after meals Unexplained nausea and vomiting that differs from your usual GLP-1-related side effects Any yellowing of the skin or whites of the eyes Dark urine or pale-coloured stools Seek immediate medical attention (attend A&E or call 999) if you develop: Severe, unrelenting abdominal pain High fever (temperature above 38C) with abdominal pain Jaundice accompanied by confusion or drowsiness Signs of sepsis, including rapid heartbeat, rapid breathing, or feeling extremely unwell When gallbladder disease is suspected, initial investigations typically include blood tests (full blood count, urea and electrolytes, liver function tests, C-reactive protein, bilirubin, and serum lipase or amylase) and abdominal ultrasonography, which is the first-line imaging modality for detecting gallstones and assessing the gallbladder

Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease

That kind of state-level overreach makes the landscape particularly risky for Kentucky providers who are prescribing and administering compounded GLP-1s within their clinical discretion

Doctors often prefer metformin for its safety record and affordability, while Ozempic is favored for significant weight loss or cardiovascular protection